Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Azithromycin controlled-release microspheres - Pfizer

Next Previous
X
Search
Drug Profile

Azithromycin controlled-release microspheres - Pfizer

Alternative Names: Azithromycin dihydrate microspheres for oral suspension - Pfizer; Azithromycin extended release - Pfizer; Azithromycin SR (2g single dose) - Pfizer; Sustained-release azithromycin - Pfizer; Zmax; Zmax for oral suspension; Zmax SR

Latest Information Update: 23 Dec 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pfizer
  • Class Anti-inflammatories; Antibacterials; Antivirals; Eye disorder therapies; Macrolides; Small molecules
  • Mechanism of Action Protein 50S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Acute exacerbations of chronic bronchitis; Acute sinusitis; Community-acquired pneumonia; Pharyngitis; Respiratory tract infections; Tonsillitis
  • Discontinued Otitis media

Most Recent Events

  • 16 Apr 2021 Discontinued - Phase-III for Community-acquired pneumonia in Japan (PO)
  • 12 Aug 2015 No recent reports on development identified - Phase-III for Community-acquired pneumonia in Japan (PO)
  • 29 Oct 2010 Launched for Acute exacerbations of chronic bronchitis in Canada (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top